Home LiteratureArticle Details
PMID: 20219702 Published · ppublish English

3.2 Mb microdeletion in chromosome 7 bands q22.2-q22.3 associated with overgrowth and delayed bone age.

European journal of medical genetics ·Vol. 53 ·No. 3 ·2010-10-12

Uliana Vera, Grosso Salvatore, Cioni Maddalena, Ariani Francesca, Papa Filomena T, Tamburello Silvia, Rossi Elisa, Katzaki Eleni, Mucciolo Mafalda, Marozza Annabella, Pollazzon Marzia, Mencarelli Maria Antonietta, Mari Francesca, Balestri Paolo, Renieri Alessandra

Abstract

We report a patient with mental retardation, epilepsy, overgrowth, delayed bone age, peculiar facial features, corpus callosum hypoplasia, enlarged cisterna magna and right cerebellar hypoplasia. Array-CGH analysis revealed the presence of a de novo 3.2 Mb interstitial deletion of the long arm of chromosome 7 involving bands q22.2-q22.3. The rearrangement includes 15 genes and encompasses a genomic region that represents a site of frequent loss of heterozygosity in myeloid malignancies. Four genes are implicated in the control of cell cycle: SRPK2, MLL5, RINT1 and LHFPL3. Haploinsufficiency of these genes might therefore be associated with overgrowth and could confer susceptibility to cancers or other tumours, so that attention to this possibility would be appropriate during regular medical review. In conclusion, array-CGH analysis should be performed in patients with overgrowth where the known causes have already been excluded, because some still unclassified overgrowth syndromes may be caused by subtle genomic imbalances.

Article Info
Journal
European journal of medical genetics
Abbr.
Eur J Med Genet
Published
2010-10-12
Indexed
2010-05-17
Updated
2016-11-22
Language
English
Country/Region
Netherlands
NLM ID
101247089
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com